Biotech Values

[cooldrinkh2o]

>>I would probably step up to buy some OSIP even before that. (I lasted owned it in Jan 05.) As previously posted, I’m looking for the Lucentis ANCHOR data to be the last hammer to create an even better buying opportunity.<<

I am stepping up Thursday. Will put in a limit order at $23.50 and write some 06 puts.

I think Tarceva sales will reaccelerate in 2006 due to the Medicare drug plan. The stock price should follow as the IMS data starts showing that renewed sales growth.